Ryan Cohlhepp
Director, President and COO; Director, President, COO & Interim CEO · 11 filings · Latest: Sep 8, 2026
Bicara Therapeutics Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
BCAX | Ryan Cohlhepp | Director, President and COO | Mar 3, 2026 | Option Exercise | $3.79 | 12,892 | $48.9K | 222,533 | |
BCAX | Cohlhepp Ryan | — | Mar 3, 2026 | Proposed Sale | $18.16 | 17,392 | $315.9K | — | |
BCAX | Ryan Cohlhepp | Director, President and COO | Feb 25, 2026 | Sale | $18.04 | 3,631 | $65.5K | 209,641 | |
BCAX | Ryan Cohlhepp | Director, President and COO | Feb 25, 2026 | Option Exercise | $3.79 | 3,108 | $11.8K | 213,272 | |
BCAX | Cohlhepp Ryan | — | Feb 25, 2026 | Proposed Sale | $18.04 | 3,631 | $65.5K | — | |
BCAX | Ryan Cohlhepp | Director, President and COO | Jan 22, 2026 | Sale | $18.10 | 3,828 | $69.3K | 210,164 | |
BCAX | Cohlhepp Ryan | — | Jan 22, 2026 | Proposed Sale | $16.97 | 3,828 | $65.0K | — | |
BCAX | Ryan Cohlhepp | Director, President and COO | Jan 15, 2026 | Sale | $18.02 | 149 | $2.7K | 213,992 | |
BCAX | Cohlhepp Ryan | — | Jan 15, 2026 | Proposed Sale | $18.02 | 149 | $2.7K | — | |
BCAX | Cohlhepp Ryan | — | Dec 15, 2025 | Proposed Sale | $18.70 | 12,500 | $233.8K | — | |
BCAX | Cohlhepp Ryan | — | Nov 21, 2025 | Proposed Sale | $18.05 | 12,500 | $225.6K | — | |
BCAX | Cohlhepp Ryan | — | Oct 15, 2025 | Proposed Sale | $18.13 | 12,500 | $226.6K | — | |
BCAX | Cohlhepp Ryan | — | Oct 7, 2025 | Proposed Sale | $18.00 | 10,900 | $196.2K | — | |
BCAX | Cohlhepp Ryan | — | Oct 6, 2025 | Proposed Sale | $18.06 | 39,600 | $715.0K | — |
← Previous
Page 2 of 2